(-)-noradrenaline   Click here for help

GtoPdb Ligand ID: 505

Synonyms: (-)-norepinephrine | Levarterenol® | noradrenaline
Approved drug PDB Ligand
(-)-noradrenaline is an approved drug (FDA (1950))
Compound class: Metabolite
Comment: Marketed formulations may contain noradrenaline tartrate (PubChem CID 25127519).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 4
Rotatable bonds 2
Topological polar surface area 86.71
Molecular weight 169.07
XLogP -0.11
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES NCC(c1ccc(c(c1)O)O)O
Isomeric SMILES NC[C@@H](c1ccc(c(c1)O)O)O
InChI InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/t8-/m0/s1
InChI Key SFLSHLFXELFNJZ-QMMMGPOBSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Natural/Endogenous Targets
Target
α1A-adrenoceptor
α1B-adrenoceptor
α1D-adrenoceptor
α2A-adrenoceptor
α2B-adrenoceptor
α2C-adrenoceptor
β1-adrenoceptor
β2-adrenoceptor
β3-adrenoceptor
Enzymes Catalysing Reactions with this Compound as a Substrate or Product
Enzyme EC number Reaction Reference
Catechol-O-methyltransferase
Dopamine beta-hydroxylase (dopamine beta-monooxygenase)
Monoamine oxidase A
Monoamine oxidase B
Phenylethanolamine N-methyltransferase
Transporters Moving this Compound Across a Lipid Membrane
Transporter EC number Reaction Reference
NET
DAT
Vesicular monoamine transporter 1 9
Vesicular monoamine transporter 2 9
Organic cation transporter 3 27
Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
α1D-adrenoceptor Ligand is endogenous in the given species Hs Agonist Full agonist 5.5 – 7.4 pKi - 13,21,23
⤷ pKi 5.5 – 7.4 [13,21,23]
α1D-adrenoceptor Ligand is endogenous in the given species Rn Agonist Full agonist 6.3 pKi - 17
⤷ pKi 6.3 [17]
α2C-adrenoceptor Primary target of this compound Ligand is endogenous in the given species Hs Agonist Full agonist 4.5 – 6.8 pKi - 15-16,18,20
⤷ pKi 4.5 – 6.8 [15-16,18,20]
α1A-adrenoceptor Ligand is endogenous in the given species Hs Agonist Full agonist 4.8 – 6.4 pKi - 7,10,13,21-23,25
⤷ pKi 4.8 – 6.4 [7,10,13,21-23,25]
α2A-adrenoceptor Ligand is endogenous in the given species Hs Agonist Full agonist 3.6 – 7.4 pKi - 15,18,20
⤷ pKi 3.6 – 7.4 [15,18,20]
β3-adrenoceptor Ligand is endogenous in the given species Hs Agonist Agonist 4.4 – 6.3 pKi - 4,6,12,19,24,26
⤷ pKi 4.4 – 6.3 [4,6,12,19,24,26]
β1-adrenoceptor Ligand is endogenous in the given species Hs Agonist Agonist 4.6 – 6.0 pKi - 4-5,11-12,24
⤷ pKi 4.6 – 6.0 [4-5,11-12,24]
α1B-adrenoceptor Ligand is endogenous in the given species Hs Agonist Full agonist 3.8 – 6.2 pKi - 21,23
⤷ pKi 3.8 – 6.2 [21,23]
β2-adrenoceptor Ligand is endogenous in the given species Hs Agonist Agonist 4.6 – 5.4 pKi - 4,11-12,14,24
⤷ pKi 4.6 – 5.4 [4,11-12,14,24]
α2B-adrenoceptor Primary target of this compound Ligand is endogenous in the given species Hs Agonist Full agonist 3.5 – 6.0 pKi - 15,18,20
⤷ pKi 3.5 – 6.0 [15,18,20]
β3-adrenoceptor Ligand is endogenous in the given species Mm Agonist Full agonist 3.8 – 5.7 pKi - 6,19,24
⤷ pKi 3.8 – 5.7 [6,19,24]
β3-adrenoceptor Ligand is endogenous in the given species Rn Agonist Agonist 4.2 pKi - 19
⤷ pKi 4.2 [19]
α1B-adrenoceptor Hs Agonist Full agonist 9.2 pEC50 - 21
⤷ pEC50 9.2 [21]
α1A-adrenoceptor Hs Agonist Full agonist 7.7 – 8.6 pEC50 - 7,10,21
⤷ pEC50 7.7 – 8.6 [7,10,21]
β3-adrenoceptor Mm Agonist Agonist 7.9 pEC50 - 6
⤷ pEC50 7.9 [6]
α1D-adrenoceptor Hs Agonist Full agonist 7.8 pEC50 - 21
⤷ pEC50 7.8 [21]
β1-adrenoceptor Mg Agonist Agonist 7.7 pEC50 - 3
⤷ pEC50 7.7 [3]
β3-adrenoceptor Hs Agonist Agonist 7.2 – 8.2 pEC50 - 1,4,6
⤷ pEC50 7.2 – 8.2 [1,4,6]
β1-adrenoceptor Hs Agonist Agonist 7.1 – 7.9 pEC50 - 2,4-5
⤷ pEC50 7.1 – 7.9 [2,4-5]
β2-adrenoceptor Hs Agonist Agonist 5.4 – 6.4 pEC50 - 4,8
⤷ pEC50 5.4 – 6.4 [4,8]
α2B-adrenoceptor Hs Agonist Full agonist 7.8 pIC50 - 20
⤷ pIC50 7.8 [20]
Description: inhibition of forskolin stimulated cAMP generation
α2C-adrenoceptor Hs Agonist Full agonist 6.5 – 8.6 pIC50 - 16,20
⤷ pIC50 6.5 – 8.6 [16,20]
Description: inhibition of cAMP production
α2A-adrenoceptor Hs Agonist Full agonist 6.6 pIC50 - 20
⤷ pIC50 6.6 [20]
Description: inhibition of forskolin stimulated cAMP generation
Additional information and targets (data relate to human unless otherwise stated)
Description Data Reference
Ligand mentioned in the following text fields